From the Journals

Severe COVID-19 linked to new diabetes diagnoses


 

COVID can more than triple the chance of being diagnosed with type 2 diabetes within a year of being infected, according to a new Canadian study.

Men who had even a mild case of COVID were significantly more likely than were noninfected men to be diagnosed with type 2 diabetes. Women didn’t have an increased risk unless they were severely ill.

Both men and women who had severe cases were at the highest risk. People who were hospitalized for COVID treatment had more than a doubled risk of being diagnosed with type 2 diabetes, and those who were admitted to intensive care units had more than a tripled risk.

“This is definitely a concern in terms of long-term outcomes,” researcher and University of British Columbia professor Naveed Z. Janjua, PhD, told The New York Times. “With a respiratory infection, you usually think, ‘Seven or eight days and I’m done with it, that’s it.’ [But] here we’re seeing lingering effects that are lifelong.”

The study was published in JAMA Network Open. Researchers analyzed health data from 2020 and 2021 for 629,935 people, 20% of whom were diagnosed with COVID during that time. Most people in the study had not been vaccinated because vaccines were not widely available then. The health information came from a registry maintained by public health officials in British Columbia. The follow-up period was 257 days.

The authors cautioned that their findings could not say that COVID causes type 2 diabetes; rather, in a commentary published along with the study, Pamela B. Davis, MD, PhD, said the link makes sense because COVID is known to impact the pancreas.

“Such a stress may move a patient from a prediabetic state into diabetes,” wrote Dr. Davis, former dean of Case Western Reserve University, Cleveland, where she is now a professor.

The researchers estimated that the increased pattern of diagnoses of diabetes following COVID infection could increase the rate of the disease occurring in the general population by 3%-5% overall.

A version of this article first appeared on WebMD.com.

Recommended Reading

Negative expectations of COVID shots may amplify side effects
MDedge Internal Medicine
Single bivalent COVID booster is enough for now: CDC
MDedge Internal Medicine
Doctor’s checklist for treating long COVID patients
MDedge Internal Medicine
Long COVID hitting some states, minorities, women harder
MDedge Internal Medicine
Long COVID: ‘On par’ with heart disease, cancer, book says
MDedge Internal Medicine
COVID caused 4.6-year drop in NYC life expectancy
MDedge Internal Medicine
As COVID tracking wanes, are we letting our guard down too soon?
MDedge Internal Medicine
New variant jumps to second place on COVID list
MDedge Internal Medicine
Sleep disturbances linked to post-COVID dyspnea
MDedge Internal Medicine
CDC backs FDA’s call for second COVID booster for those at high risk
MDedge Internal Medicine